ATE277616T1 - Synergistische kombination von roflumilast und pde-3 hemmern - Google Patents
Synergistische kombination von roflumilast und pde-3 hemmernInfo
- Publication number
- ATE277616T1 ATE277616T1 AT00927094T AT00927094T ATE277616T1 AT E277616 T1 ATE277616 T1 AT E277616T1 AT 00927094 T AT00927094 T AT 00927094T AT 00927094 T AT00927094 T AT 00927094T AT E277616 T1 ATE277616 T1 AT E277616T1
- Authority
- AT
- Austria
- Prior art keywords
- pde
- sub
- roflumilast
- inhibitors
- synergistic combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99108808 | 1999-05-04 | ||
PCT/EP2000/003838 WO2000066123A1 (en) | 1999-05-04 | 2000-04-27 | Synergistic combination comprising roflumilast and a pde-3 inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE277616T1 true ATE277616T1 (de) | 2004-10-15 |
Family
ID=8238107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00927094T ATE277616T1 (de) | 1999-05-04 | 2000-04-27 | Synergistische kombination von roflumilast und pde-3 hemmern |
Country Status (11)
Country | Link |
---|---|
US (2) | US6498173B1 (de) |
EP (1) | EP1176960B1 (de) |
JP (1) | JP2002543133A (de) |
AT (1) | ATE277616T1 (de) |
AU (1) | AU4558800A (de) |
CA (1) | CA2372850C (de) |
DE (1) | DE60014353T2 (de) |
ES (1) | ES2228512T3 (de) |
PT (1) | PT1176960E (de) |
SI (1) | SI1176960T1 (de) |
WO (1) | WO2000066123A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2407780A1 (en) * | 2000-05-25 | 2001-11-29 | Merck Frosst Canada & Co./Merck Frosst Canada & Cie | Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor |
WO2002051502A1 (en) * | 2000-12-22 | 2002-07-04 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Combined inhibition of phosphodiesterase-4 (pde-4) and phosphodiesterase-3 (pde-3) as a therapy for th1-mediated autoimmune diseases |
MY140561A (en) * | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
US6822114B1 (en) | 2002-10-08 | 2004-11-23 | Albemarle Corporation | Process for production of fluoroalkoxy-substituted benzamides and their intermediates |
DK1606261T3 (da) | 2003-03-10 | 2010-01-18 | Nycomed Gmbh | Hidtil ukendt fremgangsmåde til fremstilling af roflumilast |
DK1861074T3 (da) | 2005-03-16 | 2013-07-29 | Takeda Gmbh | Smagsmaskeret doseringsform indeholdende roflumilast |
RU2007149249A (ru) * | 2005-06-09 | 2009-07-20 | Сантен Фармасьютикал Ко., Лтд (Jp) | Глазные капли, содержащие рофлумиласт |
EP2218442A1 (de) | 2005-11-09 | 2010-08-18 | CombinatoRx, Inc. | Verfahren, Zusammensetzungen und Kits zur Behandlung von ophthalmologischen Erkrankungen |
US20210031012A1 (en) | 2018-01-26 | 2021-02-04 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor |
WO2020106757A1 (en) | 2018-11-19 | 2020-05-28 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
EP3870261B1 (de) | 2019-12-13 | 2024-01-31 | Biora Therapeutics, Inc. | Einnehmbare vorrichtung zur abgabe eines therapeutischen mittels an den magen-darm-trakt |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8929208D0 (en) * | 1989-12-27 | 1990-02-28 | Almirall Lab | New xanthine derivatives |
WO1995001338A1 (de) * | 1993-07-02 | 1995-01-12 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren |
US6110471A (en) * | 1996-09-13 | 2000-08-29 | The Board Of Trustees Of The Leland Stanford Junior University | Non-hormonal method of contraception |
US5874437A (en) * | 1996-11-01 | 1999-02-23 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
-
2000
- 2000-04-27 EP EP00927094A patent/EP1176960B1/de not_active Expired - Lifetime
- 2000-04-27 JP JP2000615008A patent/JP2002543133A/ja active Pending
- 2000-04-27 US US09/959,599 patent/US6498173B1/en not_active Expired - Lifetime
- 2000-04-27 PT PT00927094T patent/PT1176960E/pt unknown
- 2000-04-27 DE DE60014353T patent/DE60014353T2/de not_active Expired - Lifetime
- 2000-04-27 CA CA2372850A patent/CA2372850C/en not_active Expired - Lifetime
- 2000-04-27 SI SI200030562T patent/SI1176960T1/xx unknown
- 2000-04-27 AT AT00927094T patent/ATE277616T1/de active
- 2000-04-27 WO PCT/EP2000/003838 patent/WO2000066123A1/en active IP Right Grant
- 2000-04-27 ES ES00927094T patent/ES2228512T3/es not_active Expired - Lifetime
- 2000-04-27 AU AU45588/00A patent/AU4558800A/en not_active Abandoned
-
2002
- 2002-11-04 US US10/286,915 patent/US6897229B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60014353T2 (de) | 2005-10-13 |
ES2228512T3 (es) | 2005-04-16 |
CA2372850C (en) | 2011-01-18 |
AU4558800A (en) | 2000-11-17 |
US20030050329A1 (en) | 2003-03-13 |
PT1176960E (pt) | 2005-02-28 |
US6897229B2 (en) | 2005-05-24 |
EP1176960B1 (de) | 2004-09-29 |
CA2372850A1 (en) | 2000-11-09 |
DE60014353D1 (de) | 2004-11-04 |
EP1176960A1 (de) | 2002-02-06 |
US6498173B1 (en) | 2002-12-24 |
SI1176960T1 (en) | 2005-04-30 |
JP2002543133A (ja) | 2002-12-17 |
WO2000066123A1 (en) | 2000-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1202986T3 (da) | Amin- og amidderivater som ligander for neuropeptid Y-Y5-receptoren, der er nyttige ved behandlingen af obesitet og andre lidelser | |
DE60014353D1 (de) | Synergistische kombination von roflumilast und pde-3 hemmern | |
EE200300227A (et) | P38 kinaasiga seotud haigusseisundite ravimeetodid ja kinaasi inhibiitoritena kasulikud pürrolotriasiiniühendid | |
JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
NZ334476A (en) | substituted indol-3-yl glyoxylamides | |
BR0112292A (pt) | Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto | |
AU2483000A (en) | Treatment of asthma with mek inhibitors | |
DK1259485T3 (da) | Benzamider og beslægtede inhibitorer for faktor Xa | |
HUP0000487A2 (hu) | Neurokinin antagonistaként alkalmazható szubsztituált oximszármazékok | |
DK0772603T3 (da) | Substituerede pyrimidinforbindelser og deres anvendelse | |
DE60120494D1 (de) | Substituieten triazoldiamin derivaten und ihre verwendung als kinase inhibitoren | |
NO20014479D0 (no) | Fremgangsmåte ved behandling av spiseforstyrrelser | |
NO20053046L (no) | 4-okso-1(3-substituerte fenyl-1,4-dihydro-1,8-naftyridin-3-karboksamidfosfodiesterase-4-inhibitorer. | |
AU2003217074A1 (en) | N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis | |
BR9901052A (pt) | Carboxamidas heterocìclicas. | |
MXPA03009750A (es) | Compuestos quimicos. | |
WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
MXPA02012713A (es) | Combinacion de inhibidores de fructosabisfosfatasas y agentes antidiabeticos, util para el tratamiento de la diabetes. | |
HUP0003792A2 (hu) | Vegyületek antipruriticumokként történő új alkalmazása | |
ATE225657T1 (de) | Ati-rezeptorantagonisten zur verhinderung und behandlung des postischemischen nervenversagens und zum schutze ischemischer nieren | |
MXPA02012470A (es) | Inhibidores de fosfodiesterasa especificos para gmp ciclico. | |
NO923006L (no) | Akrylalkylaminer og -amider med antikonvulsante og neurobeskyttende egenskaper | |
ATE236169T1 (de) | Heterocyclisch kondensierte morphinoid-derivate | |
ATE279924T1 (de) | 3-cyclopropylmethoxy-4-difluormethoxy-n-(3,5- dichlor-pyrid-4-yl)-benzamid zur behandlung von multipler sklerose | |
MXPA03004023A (es) | Compuestos quimicos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1176960 Country of ref document: EP |
|
EEIH | Change in the person of patent owner |